Clinical Trial Update: A Phase 1/2 Trial of ADI-270 in ccRCC [Phase 1, Phase 2]

View source ↗

Summary

This is an update on the Phase 1/2 trial of ADI-270 for clear cell renal cell carcinoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• ADI-270

Snippet

Sponsor: Adicet Therapeutics | Conditions: Clear Cell Renal Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING